UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 23, 2024
Accession Number:
0001193125-24-142292
Submission Type:
POS AM
CIK:
0001626199
Company Name:
ALPINE IMMUNE SCIENCES, INC.
File Number:
333-271517